PharmaCyte Biotech, Inc. — Form D

PharmaCyte Biotech, Inc. of LAS VEGAS, NV, a company, filed a Form D exempt-offering notice with the SEC on 2013-12-27. The offering totals $3.5M, of which $1.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Robert F BowkerDirectorSILVER SPRING, MD
Richard M GoldfarbDirectorSILVER SPRING, MD
Timothy F MatulaDirectorSILVER SPRING, MD
Robert F RyanDirectorRochester, NY
Patricia L GrudenExecutive OfficerSILVER SPRING, MD
Robert M WeinsteinDirectorLAS VEGAS, NV
Jonathan L SchechterDirectorLAS VEGAS, NV
Michael M AbecassisDirectorLAS VEGAS, NV
Carlos N TrujilloExecutive OfficerLAS VEGAS, NV
Joshua N SilvermanDirectorLAS VEGAS, NV
Joshua N SilvermanExecutive OfficerLAS VEGAS, NV
Walker R WayneDirectorLAS VEGAS, NV
Thomas CK YuenDirectorLaguna Hills, CA
Crabtree W CrabtreeDirectorLaguna Hills, CA
Crabtree W CrabtreeExecutive OfficerLaguna Hills, CA
Raymond CF TongDirectorLaguna Hills, CA
Thomas CF LiquardDirectorLaguna Hills, CA
Carlos A TrujilloDirectorLaguna Hills, CA
Carlos A TrujilloExecutive OfficerLaguna Hills, CA
Gerald W CrabtreeDirectorSilver Spring, MD
Gerald W CrabtreeExecutive OfficerSilver Spring, MD
Thomas W LiquardDirectorSilver Spring, MD
Kenneth L WaggonerDirectorSilver Spring, MD
Kenneth L WaggonerExecutive OfficerSilver Spring, MD

Other filings by this issuer (3)

FiledFormOfferingSold
2025-09-04D$7.0M$7.0M
2021-09-01D$70.0M$70.0M
2016-01-19D$3.1M$1.0M

More